1. Home
  2. LVTX

as 01-08-2025 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.

;SMA (50)$1.46EMA (200)$1.78O: $1.10 H: $1.10 L: $1.02 C: $1.02 −0.08 (−7.27%)Elder Ray 0.09, 0.01
Founded: 2016 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 27.9M IPO Year: 2021
Target Price: $3.33 AVG Volume (30 days): 208.1K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.02 EPS Growth: N/A
52 Week Low/High: $0.88 - $6.47 Next Earning Date: 12-10-2024
Revenue: $7,345,000 Revenue Growth: -18.89%
Revenue Growth (this year): -4.65% Revenue Growth (next year): N/A

LVTX Daily Stock ML Predictions

SELLHOLDBUYas of 16 hours ago

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use